Elevai Labs, Inc. Common Stock (ELAB) — Financial Flexibility Index
Elevai Labs, Inc. Common Stock (ELAB) has a Financial Flexibility Index of -0.33x as of December 2025. Free cash flow of $-1.65 Million (operating CF $-1.75 Million minus capex $95.59K) represents 0% of total liabilities ($5.03 Million). Check Elevai Labs, Inc. Common Stock PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elevai Labs, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Elevai Labs, Inc. Common Stock across 6 annual periods. See Elevai Labs, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Elevai Labs, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Elevai Labs, Inc. Common Stock. For the full company profile including market capitalisation, see ELAB market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.09x | $-5.49 Million | $-5.93 Million | $5.03 Million | ▲ +53.6% |
| 2024 | -2.35x | $-5.48 Million | $-5.49 Million | $2.33 Million | ▲ +29.6% |
| 2023 | -3.34x | $-4.55 Million | $-4.56 Million | $1.36 Million | ▼ -63.7% |
| 2022 | -2.04x | $-1.55 Million | $-1.59 Million | $760.87K | ▲ +30.1% |
| 2021 | -2.91x | $-628.45K | $-660.93K | $215.62K | ▲ +45.5% |
| 2020 | -5.35x | $-217.16K | $-217.16K | $40.61K | — |